BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 1423947)

  • 1. Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects.
    Brunken RC; Mody FV; Hawkins RA; Nienaber C; Phelps ME; Schelbert HR
    Circulation; 1992 Nov; 86(5):1357-69. PubMed ID: 1423947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
    Brunken RC; Mody FV; Hawkins RA; Nienaber CA; Phelps ME; Schelbert HR
    Herz; 1994 Feb; 19(1):28-41. PubMed ID: 8150412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.
    Dilsizian V; Perrone-Filardi P; Arrighi JA; Bacharach SL; Quyyumi AA; Freedman NM; Bonow RO
    Circulation; 1993 Sep; 88(3):941-52. PubMed ID: 8353921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
    Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional left ventricular wall thickening. Relation to regional uptake of 18fluorodeoxyglucose and 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction.
    Perrone-Filardi P; Bacharach SL; Dilsizian V; Maurea S; Frank JA; Bonow RO
    Circulation; 1992 Oct; 86(4):1125-37. PubMed ID: 1394920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease.
    Rossetti C; Landoni C; Lucignani G; Huang G; Bartorelli AL; Guazzi MD; Margonato A; Chierchia S; Galli L; Savi A
    Eur J Nucl Med; 1995 Nov; 22(11):1306-12. PubMed ID: 8575482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential uptake and apparent 201Tl washout after thallium reinjection. Options regarding early redistribution imaging before reinjection or late redistribution imaging after reinjection.
    Dilsizian V; Bonow RO
    Circulation; 1992 Mar; 85(3):1032-8. PubMed ID: 1537101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET detection of viable tissue in myocardial segments with persistent defects at T1-201 SPECT.
    Brunken RC; Kottou S; Nienaber CA; Schwaiger M; Ratib OM; Phelps ME; Schelbert HR
    Radiology; 1989 Jul; 172(1):65-73. PubMed ID: 2787037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction.
    Kauffman GJ; Boyne TS; Watson DD; Smith WH; Beller GA
    J Am Coll Cardiol; 1996 Jun; 27(7):1592-7. PubMed ID: 8636541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of thallium-201 single-photon emission tomography after rest injection and fluorodeoxyglucose positron emission tomography for assessment of myocardial viability in patients with chronic coronary artery disease.
    Altehoefer C; vom Dahl J; Buell U; Uebis R; Kleinhans E; Hanrath P
    Eur J Nucl Med; 1994 Jan; 21(1):37-45. PubMed ID: 8088284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic myocardial viability assessment with iodine 123-16-iodo-3-methylhexadecanoic acid in recent myocardial infarction: comparison with thallium-201 and fluorine-18 fluorodeoxyglucose.
    Vanzetto G; Janier M; Fagret D; Cinotti L; André-Fouet X; Comet M; Machecourt J
    Eur J Nucl Med; 1997 Feb; 24(2):170-8. PubMed ID: 9021114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects.
    Brunken R; Schwaiger M; Grover-McKay M; Phelps ME; Tillisch J; Schelbert HR
    J Am Coll Cardiol; 1987 Sep; 10(3):557-67. PubMed ID: 3497966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of assessing regional myocardial uptake of 18F-fluorodeoxyglucose using single photon emission computed tomography.
    Bax JJ; Visser FC; van Lingen A; Huitink JM; Kamp O; van Leeuwen GR; Visser GW; Teule GJ; Visser CA
    Eur Heart J; 1993 Dec; 14(12):1675-82. PubMed ID: 8131767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.
    Dilsizian V; Arrighi JA; Diodati JG; Quyyumi AA; Alavi K; Bacharach SL; Marin-Neto JA; Katsiyiannis PT; Bonow RO
    Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography.
    Stoll HP; Hellwig N; Alexander C; Ozbek C; Schieffer H; Oberhausen E
    Eur J Nucl Med; 1994 Oct; 21(10):1085-93. PubMed ID: 7828618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative planar imaging of glucose metabolic activity in myocardial segments with exercise thallium-201 perfusion defects in patients with myocardial infarction: comparison with late (24-hour) redistribution thallium imaging for detection of reversible ischemia.
    Williams KA; Taillon LA; Stark VJ
    Am Heart J; 1992 Aug; 124(2):294-304. PubMed ID: 1636573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of myocardial perfusion and metabolism for assessment of myocardial viability.
    Beller GA
    Q J Nucl Med; 1996 Mar; 40(1):55-67. PubMed ID: 8681014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial thallium-201 scintigraphy for assessment of viability in patients with severe left ventricular dysfunction.
    Beller GA; Ragosta M; Watson DD; Gimple LW
    Am J Cardiol; 1992 Nov; 70(14):18E-22E. PubMed ID: 1442567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
    Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
    J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorine 18-labeled fluorodeoxyglucose myocardial single-photon emission computed tomography: an alternative for determining myocardial viability.
    Sandler MP; Patton JA
    J Nucl Cardiol; 1996; 3(4):342-9. PubMed ID: 8799254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.